Sabra Health Care REIT (NASDAQ:SBRA) Posts Earnings Results

Sabra Health Care REIT (NASDAQ:SBRA) announced its quarterly earnings results on Wednesday. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.36, Zacks reports. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.

Sabra Health Care REIT Stock Performance

SBRA traded up $0.09 on Wednesday, hitting $16.55. 2,383,460 shares of the stock traded hands, compared to its average volume of 2,028,542. Sabra Health Care REIT has a 52 week low of $13.31 and a 52 week high of $20.03. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $3.92 billion, a PE ratio of 40.37, a P/E/G ratio of 1.99 and a beta of 1.25. The business has a fifty day moving average price of $16.92 and a two-hundred day moving average price of $17.63.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 7.25%. Sabra Health Care REIT’s dividend payout ratio is 292.69%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SBRA. Mizuho reaffirmed a “neutral” rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their price objective for the stock from $18.00 to $17.00 in a research report on Friday, January 17th. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Finally, JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research report on Tuesday, January 7th. Three research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.